SS Innovations said on June 30 that it won the “outstanding company” category at the 2026 Surgical Robotics Industry Awards, beating nine other finalists.
The company also reported that, as of June 22, 2026, cumulative procedures performed with its SSI Mantra surgical robotic system reached 11,719. That total included 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries.
Training on the system has reached about 2,100 physicians, and the platform has been used for more than 170 different types of procedures.
SS Innovations said the SSI Mantra has now received regulatory approval in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine and the United Arab Emirates. Today the company's shares have moved 6.26% to a price of $3.751. If you want to know more, read the company's complete 8-K report here.
